Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hepatitis D

and liver cancer may ensue from Hepatitis D.Hepatitis D is a disease caused by a small circular RNA virus . HDV is considered to be a subviral satellite because it can propagate only in the presence of another virus, the hepatitis B virus . Transmission of HDV can occur either via simultaneous infection with HBV or via infection of an individual previously infected with HBV . Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a greater likelihood of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%. and liver cancer may ensue from Hepatitis D.Hepatitis D is a disease caused by a small circular RNA virus . HDV is considered to be a subviral satellite because it can propagate only in the presence of another virus, the hepatitis B virus . Transmission of HDV can occur either via simultaneous infection with HBV or via infection of an individual previously infected with HBV . Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a greater likelihood of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%. (From the Wikpedia article Hepatitis D.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hepatitis D:

Pubmed Logo
[Etiopathological factors of hepatocellular carcinoma in Bangui, Central African Republic: Clinical, biological characteristics and virological aspects of patients.]
OBJECTIVES: To describe clinical, biological characteristics and...
31st October, 2009
Laboratoire des hepatites virales, institut Pasteur de Bangui, BP 923, Pathol Biol (Paris). 2009 Oct 27.
DOI Direct Link
Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region.
The genotypes of hepatitis B (HBV) and delta (HDV) viruses circulating...
31st October, 2009
Laboratory of Tropical Hepatology and Gastroenterology, Tropical Medicine J Gen Virol. 2009 Nov;90(Pt 11):2638-43. Epub 2009 Jul 15.
DOI Direct Link
Prevalence and phylogenetic analysis of hepatitis B virus among nonhuman primates in Taiwan.
Hepatitis B virus (HBV) is a public health problem worldwide, and apart...
23rd October, 2009
Department of Veterinary Medicine, National Pingtung University of Science J Zoo Wildl Med. 2009 Sep;40(3):519-28.
Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland.
Summary. Hepatitis B virus (HBV) infection is endemic in Greenland with...
29th September, 2009
Department of Epidemiology Research, Statens Serum Institut, Copenhagen, J Viral Hepat. 2009 Sep 25.
DOI Direct Link
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
The aim of this study was to determine the prevalence of hepatitis B virus...
24th September, 2009
Dipartimento di Medicina Interna, Universita di Genova, Genova 16132, J Med Virol. 2009 Nov;81(11):1882-6.
DOI Direct Link

View more research publications.

Press Releases About Hepatitis D:

BioPortfolio Logo
Aethlon Medical Announces Collaboration to Identify Brain Trauma Biomarkers 3rd November, 2009 Aethlon Medical, Inc.
SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it has initiated a collaborative biomarker discovery program with the Center for the
MinuteClinic Becomes Participating Provider With Blue Cross and Blue Shield of Oklahoma 3rd November, 2009 MinuteClinic
MINNEAPOLIS, Nov. 3 /PRNewswire/ -- MinuteClinic, the pioneer and largest provider of retail health care in the United States, announced that it has become a participating provider with Blue Cross and
Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting 3rd November, 2009 Valeant Pharmaceuticals International
ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that results from the week-72 analysis for its Phase IIb dose-finding clinical trial for
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 2nd November, 2009 Schering-Plough Corporation
BOSTON, Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational,
Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting 2nd November, 2009 Sanofi Pasteur
PHILADELPHIA, Nov. 2 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), presented Safety of a Quadrivalent (A,C,Y,W-135) Meningococcal Vaccine

BioNews Results for Hepatitis D:

RSS Logo
BioPortfolio Logo
Rep Honda Introduces Bi-Partisan Bill to End Hepatitis Epidemic in America
National AIDS Treatment Advocacy Project:  Oct 30 2009 11:27AM Matching: hepatitis d
Concert Pharmaceuticals' Roger Tung Awarded 2009 Mass High Tech All Star Award
Forbes.com:  Oct 29 2009 12:53PM Matching: hepatitis d
Concert Pharmaceuticals' Roger Tung Awarded 2009 Mass High Tech All Star Award
Pharma Live:  Oct 29 2009 12:38PM Matching: hepatitis d
Concert Pharmaceuticals' Roger Tung Awarded 2009 Mass High Tech All Star Award
Business Wire via Yahoo!:  Oct 29 2009 12:32PM Matching: hepatitis d
Concert PharmaceuticalsEUR Roger Tung Awarded 2009 Mass High Tech All Star Award
Business Wire:  Oct 29 2009 11:51AM Matching: hepatitis d
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Hepatitis D Clinical Trials:

Clinical Trials Logo
Pegylated Interferon to Treat Chronic Hepatitis D

Hepatitis D Patents:

USPTO Logo
US Patent No.Title
7468423 Homogeneous preparations of IL-28 and IL-29
7504107 Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
7504515 Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate
7507413 Albumin fusion proteins
7507414 Albumin fusion proteins

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hepatitis D scientists - we have details of around 193 individuals working on Hepatitis D .


This page has been viewed 478 times
Recent Search Terms used to find this page: All about Hepatitis D | hepatitis d complication | hepatitis d complications | hepatitis d pdf | Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. | Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. | SUUMARY doctors warn on hepA B | hepatitis d complications | hepatitis d pdf | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hepatitis D across BioPortfolio, or for Hepatitis D Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.